Sun On Progressing Antibe’s Non-Opioid Analgesic, Challenges In Japan

Sun Scion Elevated As COO

 
• By Anju Ghangurde
  
Progress asset
Sun to steer Antibe's novel NSAID (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from R&D